Business · 27/07/1995Updated: 10/18/2026 · 1 min read
FDA Proposes Amendment to OTC Bronchodilator Drug Products to Remove Ephedrine Ingredients
Summary
The FDA is proposing to amend the monograph for OTC bronchodilator drug products to remove ephedrine and its derivatives due to concerns over their misuse and potential harm, in response to a request from the DEA and comments from advisory committees.